Posted by Michael Wonder on 30 Nov 2021
Updated 2021 – 22 cost recovery implementation statement
30 November 2021 - The 2021-22 Pharmaceutical Benefits Scheme and National Immunisation Plan Cost Recovery Implementation Statement has been updated to report financial and non-financial results for the 2020-21 financial year.
The statement provides information for industry on how the Department administers cost recovery arrangements and sets out the fees that apply for PBS/NIP applications in the 2021-22 financial year.
